Use of colloidal silicon dioxide for treating sickle-cell anemia, malaria and exogenously induced leukopenias

摘要

PCT No. PCT/EP94/01056 Sec. 371 Date Sep. 21, 1995 Sec. 102(e) Date Sep. 21, 1995 PCT Filed Apr. 5, 1994 PCT Pub. No. WO94/22456 PCT Pub. Date Oct. 13, 1994The use of colloidal silica for the treatment of sickle-cell anaemia, malaria and exogenously induced leucopenias leads to a significant improvement in the condition of the patients.